We are live on ! Find out more
ABBV icon

AbbVie

4,263 hedge funds and large institutions have $338B invested in AbbVie in 2026 Q2 according to their latest regulatory filings, with 286 funds opening new positions, 1,941 increasing their positions, 1,559 reducing their positions, and 112 closing their positions.

New
Increased
Maintained
Reduced
Closed

155% more first-time investments, than exits

New positions opened: 286 | Existing positions closed: 112

101% more capital inflows, than outflows

Capital inflows: $22.4B | Capital outflows: $11.1B

25% more repeat investments, than reductions

Existing positions increased: 1,941 | Existing positions reduced: 1,559

20% more call options, than puts

Call options by funds: $3.81B | Put options by funds: $3.17B

15% more funds holding in top 10

Funds holding in top 10: 175 → 201 (+26)

3% more funds holding

Funds holding: 4,138 → 4,263 (+125)

2.56% more ownership

Funds ownership: 73.5% → 76.06% (+2.6%)

Holders
4,263
Holders Change
+125
Holders Change %
+3.02%
% of All Funds
50.74%
Holding in Top 10
201
Holding in Top 10 Change
+26
Holding in Top 10 Change %
+14.86%
% of All Funds
2.39%
New
286
Increased
1,941
Reduced
1,559
Closed
112
Calls
$3.81​B
Puts
$3.17​B
Net Calls
+$634​M
Net Calls Change
+$920​M

ABBV Hedge Fund Activity: Q2 2026 in Review

4,263 of the 8,401 institutional investors tracked by Wall St. Rank reported a position in AbbVie (ABBV) for Q2 2026, worth a combined $338B — up 20% from $282B a quarter earlier.

Buyers outnumbered sellers: 286 funds opened new ABBV positions and 112 closed out — a net gain of 174 holders — while 1,941 added to existing stakes and 1,559 trimmed.

The largest buyer was Royal Bank of Canada, adding an estimated $1.89B. The largest seller was JP Morgan Chase, cutting an estimated $1.91B.

  • 4,263 institutional investors held AbbVie (ABBV) as of Q2 2026, up from 4,138 in Q1 2026.
  • Funds reported $338B of AbbVie stock for Q2 2026, up 20% quarter-over-quarter.
  • 286 funds opened new AbbVie positions in Q2 2026 and 112 closed out, a net change of +174 holders.
  • The largest AbbVie buyer in Q2 2026 was Royal Bank of Canada, an estimated $1.89B added.
  • The largest AbbVie seller in Q2 2026 was JP Morgan Chase, an estimated $1.91B sold.

Based on aggregated 13F filings for Q2 2026.